Targeted ACT Compared to Supportive Therapy for Depression RCT
Launched by WESTERN MICHIGAN UNIVERSITY · Mar 21, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- • Scored one SD below the mean on the RSES and BSI
- • Proficiency in English
- • If taking medication for psychiatric reasons, stable medication use for at least eight weeks prior to enrollment and agreement to no changes in dosing during study participation.
- Exclusion Criteria:
- • Receiving other forms of psychological treatment
- • Meeting PDSQ Interview criteria for psychosis, panic disorder, substance use, or endorsement of significant suicidal ideation
About Western Michigan University
Western Michigan University (WMU) is a leading research institution dedicated to advancing health sciences through innovative clinical trials and studies. With a focus on enhancing patient care and outcomes, WMU leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous research in collaboration with various healthcare partners. The university is committed to ethical standards and the highest quality of research practices, aiming to contribute valuable insights to the medical community and improve public health. Through its clinical trials, WMU seeks to address critical health challenges and foster the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported